Annual Report 2003 Aventis - Sanofi

Nutrition and Aventis CropScience in 2002. In addition,
sales were negatively impacted by currency
translation, which reduced reported net sales by
approximately 9.4 %, principally due to the decline
of the U.S. dollar and of Latin American currencies
relative to the euro.
The ongoing strong performance of strategic
brands and vaccines were the primary drivers of the
core business sales performance in 2003. Sales of
strategic brands (brand-name pharmaceuticals that
we believe have signifi cant commercial potential
and on which we focus our marketing efforts) and
human vaccines totaled e 10 851 million, a 17.0 %
>> 49